Oral medicinal composition for patients undergoing peritoneal dialysis and method for using same

摘要

The present invention provides an oral medicinal composition for patients undergoing peritoneal dialysis, which is to be used for preventing an increase in carbonyl compounds and/or advanced glycation end-products (AGEs) in the abdominal cavity and peritoneum tissue after intraperitoneally administration of a glucose-containing peritoneal dialysis fluid. Said oral medicinal composition comprises, as the active ingredient, a pharmaceutically acceptable salt of pyridoxamine.